Ingredients :
Trivrit (Operculina turpethum), Musta (Cyperus rotundus), Vidanga (Embelia ribes), Haritaki (Terminalia chebula), Bibhitaki (Terminalia bellirica), Amalaki (Emblica officinalis), Pippali (Piper longum), Maricha (Piper nigrum), Shunthi (Zingiber officinale), Ela (Elettaria cardamomum), Lavanga (Syzygium aromaticum), Patra / Tejpatra (Cinnamomum tamala), Sugar (Sharkara).
Enter your pincode to check serviceability
| Expiry | Best before 24 months from the date of manufacture |
| Manufactured By |
Shree VishwamitraAyurved Pharmaceuticals Private Limited 256/A Mahagujarat Industrial Estate, Village: Moraiya, Ta: Sanand, District: Ahmedabad 382213. Gujarat. |
| Return Period | Returns accepted within 2 days from the receiptance of delivery. |
Avipattikar Tablet (A.Bh.) is a classical Ayurvedic formulation mentioned in the Ayurvedic Pharmacopoeia of India.
It is primarily used as a natural antacid and digestive remedy. The formulation helps balance excess pitta dosha, reduces acidity, relieves indigestion, and supports healthy bowel movements.
Note:- This is a pure classical Ayurvedic medicine and should be strictly consumed only after prescription of an Ayurvedic doctor and taken under medical supervision.
| Pack (Tab): | 90, 900 |
|---|
Avipattikar Tablet is prepared using a traditional mixture of herbs and natural ingredients such as Trikatu (Pippali, Maricha, Shunthi), Trivrut, Musta, Haritaki, Amalaki, Bibhitaki, Vidanga, Ela, Lavanga, Patra, Sugar, and others.
The powders are blended in precise proportions as per Ayurvedic standards, then processed and compressed into tablet form for ease of use.
1 to 2 tablets, once or twice a day, preferably after meals with warm water, or as directed by the physician.
Generally safe when taken in prescribed dosage. Overdose may cause loose stools or abdominal discomfort.
- Should be taken cautiously in patients with diarrhea or loose motions.
- Pregnant and lactating women should take only under medical supervision.
Available Sizes / Packs: 90, 900
There are no reviews yet.